A recent meta-analysis, including 13,871 BRCA1/2 mutation carriers, evaluating the prevalence of endometrial cancer reported a slightly increased risk, mainly for BRCA1, but the absolute risk remained low [23]. This evidence concerns the gene BRCA1 and endometrial cancer.